127 related articles for article (PubMed ID: 6453036)
21. Spontaneous suppressor cell activity in the peripheral blood of patients with malignant and chronic inflammatory bowel diseases.
Doldi K; Manger B; Koch B; Riemann J; Hermanek P; Kalden JR
Clin Exp Immunol; 1984 Mar; 55(3):655-63. PubMed ID: 6231146
[TBL] [Abstract][Full Text] [Related]
22. Circulating lymphocyte subpopulations in Crohn's disease.
Yuan SZ; Hanauer SB; Kluskens LF; Kraft SC
Gastroenterology; 1983 Dec; 85(6):1313-8. PubMed ID: 6605274
[TBL] [Abstract][Full Text] [Related]
23. Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease.
Goodacre RL; Bienenstock J
Gastroenterology; 1982 Apr; 82(4):653-8. PubMed ID: 7060886
[TBL] [Abstract][Full Text] [Related]
24. Suppressor function of T lymphocytes in the acquired immunodeficiency syndrome as assessed by allogeneic mixed lymphocyte culture.
Lin RY; Tanz WS; Denny TN
J Clin Lab Immunol; 1985 Feb; 16(2):69-73. PubMed ID: 3157802
[TBL] [Abstract][Full Text] [Related]
25. Phenotype and functional properties of Vicia villosa agglutinin (VVA) binding T cells in patients with Crohn's disease: detection of contrasuppressor activity in patients lacking extra-intestinal manifestations, abscesses and fistulas.
Raedler A; Lenz HJ; Sandgren K; de Weerth A; Enversen S; Schreiber S; Thiele HG; Greten H
Clin Exp Immunol; 1988 Nov; 74(2):264-9. PubMed ID: 2465109
[TBL] [Abstract][Full Text] [Related]
26. Enhanced suppressor T cell activity resulting in increased IgM and decreased IgG productions in children with minimal change nephrotic syndrome.
Chen CH; Hsieh KH; Lee PP
Int J Pediatr Nephrol; 1987; 8(2):75-80. PubMed ID: 2958423
[TBL] [Abstract][Full Text] [Related]
27. Alteration in T lymphocyte subpopulations in inflammatory bowel disease.
Victorino RM; Hodgson HJ
Clin Exp Immunol; 1980 Jul; 41(1):156-65. PubMed ID: 6969150
[TBL] [Abstract][Full Text] [Related]
28. Immunoregulatory function of lamina propria T cells in Crohn's disease.
James SP; Fiocchi C; Graeff AS; Strober W
Gastroenterology; 1985 May; 88(5 Pt 1):1143-50. PubMed ID: 2858428
[TBL] [Abstract][Full Text] [Related]
29. Abnormal regulation of in vitro IgG production in multiple sclerosis.
Kelly RE; Ellison GW; Myers LW; Goymerac V; Larrick SB; Kelley CC
Ann Neurol; 1981 Mar; 9(3):267-72. PubMed ID: 6452852
[TBL] [Abstract][Full Text] [Related]
30. Selective IgM deficiency in adults: phenotypically and functionally altered profiles of peripheral blood lymphocytes.
Ohno T; Inaba M; Kuribayashi K; Masuda T; Kanoh T; Uchino H
Clin Exp Immunol; 1987 Jun; 68(3):630-7. PubMed ID: 2958191
[TBL] [Abstract][Full Text] [Related]
31. Infliximab downregulates interferon-gamma production in activated gut T-lymphocytes from patients with Crohn's disease.
Agnholt J; Kaltoft K
Cytokine; 2001 Aug; 15(4):212-22. PubMed ID: 11563881
[TBL] [Abstract][Full Text] [Related]
32. Abnormal B cell differentiation and variable increased T cell suppression in immunodeficiency with hyper-IgM.
Krantman HJ; Stiehm ER; Stevens RH; Saxon A; Seeger RC
Clin Exp Immunol; 1980 Apr; 40(1):147-56. PubMed ID: 6446430
[TBL] [Abstract][Full Text] [Related]
33. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
34. Differences in the immunoglobulin synthesis by peripheral blood lymphocytes in Crohn's disease and ulcerative colitis.
Verspaget HW; Peña AS; Weterman IT; Lamers CB
Digestion; 1987; 38(4):245-53. PubMed ID: 3447918
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticosteroid enhancement of immunoglobulin synthesis by pokeweed mitogen-stimulated human lymphocytes. III. Common variable immunodeficiency.
Cooper DA; Hansen P; Duckett M; Ziegler JB; Penny R
Clin Exp Immunol; 1981 Aug; 45(2):399-408. PubMed ID: 6976248
[TBL] [Abstract][Full Text] [Related]
36. Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease.
Probert CS; Chott A; Turner JR; Saubermann LJ; Stevens AC; Bodinaku K; Elson CO; Balk SP; Blumberg RS
J Immunol; 1996 Oct; 157(7):3183-91. PubMed ID: 8816432
[TBL] [Abstract][Full Text] [Related]
37. Morphological characterisation of Crohn's disease fistulae.
Bataille F; Klebl F; Rümmele P; Schroeder J; Farkas S; Wild PJ; Fürst A; Hofstädter F; Schölmerich J; Herfarth H; Rogler G
Gut; 2004 Sep; 53(9):1314-21. PubMed ID: 15306592
[TBL] [Abstract][Full Text] [Related]
38. Immunological studies on Crohn's disease. II. Lack of evidence for humoral and cellular dysfunctions.
Fujita K; Okabe N; Yao T
J Clin Lab Immunol; 1985 Mar; 16(3):155-61. PubMed ID: 3162025
[TBL] [Abstract][Full Text] [Related]
39. Suppressor cell defect in SLE: relationship to native DNA binding.
Krakauer RS; Clough JD; Alexander T; Sundeen J; Sauder DN
Clin Exp Immunol; 1980 Apr; 40(1):72-6. PubMed ID: 6446432
[TBL] [Abstract][Full Text] [Related]
40. New aspects for the therapy of Crohn's disease.
Rohr G; Usadel KH
Klin Wochenschr; 1990; 68 Suppl 21():64-8. PubMed ID: 2142969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
